PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1372010
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1372010
According to Stratistics MRC, the Global Cognitive Neuroscience Market is accounted for $36.72 billion in 2023 and is expected to reach $62.93 billion by 2030 growing at a CAGR of 8% during the forecast period. Understanding the neurological processes underpinning human cognition, including perception, memory, language, decision-making, and problem-solving, is the focus of the interdisciplinary study of cognitive neuroscience. It integrates components of psychology, neurology, and other relevant fields to look into how the brain manages different cognitive processes. Based on governmental goals, public interest, and monetary situations, the level of financing may change. Some pharmaceutical firms could create medications and therapies that target cognitive processes, which might be useful for treating Alzheimer's disease, ADHD, or enhancing cognitive abilities.
According to the Parkinson's Foundation organization approximately one million people will be living with Parkinson's disease (PD) in the United States by the end of the year 2020, and nearly 60,000 Americans are diagnosed with Parkinson's disease each year.
The market for cognitive neuroscience has been significantly shaped and driven by developments in neuroimaging technologies. These developments have made it possible for researchers to learn more about the neurological underpinnings of human cognition and behaviour. High-resolution structural and functional brain imaging has been made possible by improvements in MRI technology. Moreover, the stronger magnetic fields in high-field MRI scanners (such the 3T and 7T) produce better, more precise pictures of brain structures and functional activity. Researchers can now record brain activity at a higher temporal resolution because to advancements in fMRI techniques including multiband imaging and quicker acquisition methods.
For researchers, universities, and organizations wishing to undertake studies or clinical assessments, the price of equipment and technology in the cognitive neuroscience industry can be a substantial obstacle. The specialized and cutting-edge nature of the machinery and technology used in cognitive neuroscience research is mostly to blame for the high expenses. The cost of purchasing and maintaining high-field MRI scanners, such the 3 Tesla (3T) and 7 Tesla (7T), is high. The price of radiotracers, PET scanners, and facility upkeep might be high. It can be expensive to purchase high-performance computers with specialized hardware for data analysis. Licensing costs are frequently associated with proprietary software tools for neuroimaging and data processing which hampers the growth of the market.
Cognitive neuroscience is used to the field of education to provide methods and resources that enhance learning results. Platforms for individualized learning and adaptable instructional materials are some of these strategies. The market for cognitive neuroscience includes strategies to ease stress, enhance emotional control, and increase mental toughness since they can directly affect cognitive function. For professionals in a variety of disciplines, including military people, athletes, and corporate leaders, several organizations provide specific training programs. There is continuing research into the creation of medications that target cognitive processes. These medications aim to improve memory, focus, or other cognitive functions. They can be applied in therapeutic circumstances or to improve cognitive function in healthy people.
The time needed for research and development in cognitive neuroscience might be significantly increased by ethical and regulatory evaluations. Studies' beginning and ending dates may be delayed due to obtaining ethical permission and negotiating regulatory procedures, thereby slowing the rate of scientific advancement. The price of adhering to ethical and legal obligations is sometimes higher. These might include the costs of maintaining appropriate research methods, administrative expenditures for compliance, and fees for ethical review board membership. Moreover, it may be difficult logistically and administratively to undertake cross-border research since researchers frequently have to manage a variety of foreign rules and ethical requirements.
Lockdowns, social distancing techniques, and limitations on lab and research operations caused several cognitive neuroscience research projects and studies to be halted or postponed. Access to research facilities and participant recruitment were difficult for researchers, which may have impacted project timeframes and data collecting. Governments and organizations cut back on spending and rearranged their priorities for sponsoring research as a result of the epidemic. Research funds for cognitive neuroscience may have been diverted to COVID-19-related initiatives in some cases.
The encephalography (EEC) segment is estimated to have a lucrative growth, as it is frequently used to examine brain activity linked to several cognitive functions, including attention, memory, language, and emotion. Software and methods for analysing EEC data are crucial for cognitive neuroscience researchers. These programs enable the processing and analysis of its data in order to glean knowledge about the functioning of the brain during cognitive activities. In order to teach people how to control or modify their brain activity, neurofeedback employs EEC to present them with real-time feedback. Applications for this include improving cognitive function and reducing stress which boost the growth of the market.
The instruments segment is anticipated to witness the highest CAGR growth during the forecast period, because the study of brain activity, behaviour, and cognition heavily relies on the tools employed in cognitive neuroscience. For data collection, processing, and interpretation in several research and clinical applications, these tools are crucial. Neuroimaging equipment, electroencephalography (EEG), transcranial magnetic stimulation (TMS), and transcranial direct current stimulation (tDCS) are a few of the frequently used equipment and technologies in the cognitive neuroscience sector. Additionally, continuous technical progress, such as the creation of more portable and inexpensive neuroimaging technologies and better data analysis methods, characterizes the market for cognitive neuroscience instruments. These tools are frequently used to learn more about cognitive processes, brain illnesses, and prospective therapies for cognitive improvement and rehabilitation in both research and therapeutic settings.
Asia Pacific is projected to hold the largest market share during the forecast period owing the region's rising incidence of dementia may be largely blamed for the market's growth. The biggest percentage of people worldwide living with dementia is believed to be in the Asia Pacific area. Dementia cases are predicted to increase as the population ages, which are predicted to boost the demand for cognitive neuroscience in the area. For instance, by offering insights into the neurological pathways, cognitive neuroscience aids in the prevention and treatment of dementia.
North America is projected to have the highest CAGR over the forecast period, owing to the rising prevalence of anxiety and depression in the area has led to an increase in the need for cognitive neuroscience, therefore market expansion in the region is also anticipated. For instance, in the United States, 4.91% of people have a severe psychiatric condition. State-by-state, the prevalence of adult mental illnesses ranges from 16.37% in New Jersey to 26.86% in Utah which are propelling the growth of the market.
Some of the key players profiled in the Cognitive Neuroscience Market include: Danaher Corp, Carl Zeiss AG, Siemens Healthcare Private Limited, Canon Inc, Medtronic, Stryker, Boston Scientific Corp, ABBOTT, Koninklijke Philips N.V, Terumo Corp, B. Braun SE, Alpha Omega Inc., Biobserve GmbH, NeuroNexus Technology, Laserglow Technologies, Kendall Research Systems LLC and Scientifica Ltd.
In October 2023, ZEISS Medical Technology and Boehringer Ingelheim announced a long-term strategic collaboration to develop predictive analytics to enable early detection of eye diseases and more personalized treatments to prevent vision loss for people with serious eye diseases.
In October 2023, Nanoimprint lithography semiconductor manufacturing system that covers diverse applications with simple patterning mechanism, which executes circuit pattern transfer, the most important semiconductor manufacturing process.
In March 2023, Danaher Corporation a global science and technology innovator, announced a strategic partnership with the University of Pennsylvania (Penn) focusing on cell therapy innovation.